Profiling extravillous trophoblasts in cervical fluid reveals biomarkers for predicting preeclampsia, highlighting early placental signals.
Preeclampsia (PE) remains difficult to predict, particularly when it manifests late in gestation. To capture early placental signals, we profiled trophoblast cells sampled from the cervix in the first trimester using mass cytometry (CyTOF). We established protocols for clinical sample storage and applied spike-in reference control cells to deliver reproducible, batch-corrected protein measurements, thereby advancing CyTOF from a discovery tool to a translational platform. Within HLA-G⁺CD45⁻ cells, we identified canonical CK7⁺ extravillous trophoblasts, as well as a previously unrecognized CK7⁻ subset, and both subsets expressed placental proteins. Expression of PAPP-A, GAL-13, and GAL-14 was significantly altered in a pilot cohort of pregnancies that subsequently developed late-onset PE, distinguishing cases from controls at both single-marker and multivariate levels. These findings reveal unexpected trophoblast heterogeneity, demonstrate that placental alterations are detectable before the development of late-onset PE, and establish cervical trophoblast profiling as a promising platform for scalable biomarker discovery and first-trimester risk assessment in placenta-mediated disorders.
No takes yet. Share an insight, caveat, or question.
Kalkat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: